ALS Treatment with Growth Hormone Therapy Work to Continue
Because amyotrophic lateral sclerosis (ALS) is such a devastating disease, there is a need for novel and efficacious therapies and several…
Articles by Margarida Azevedo, MSc
ALS Consortium Opens a Request for Phase II Clinical Trial Applications
A consortium dedicated to finding a cure for amyotrophic lateral sclerosis (ALS), comprised of ALS ACT, The ALS Association, ALS Finding a Cure,…
ALS Promising Therapies Take Center Stage at Researchers’ Meeting
An ALS Association-sponsored meeting, held at Cold Spring Harbor Laboratory in Huntington, New York, brought together expert researchers to discuss…
Rutgers Awarded $6M Grant to Manage NINDS Stem Cell Repository
The Rutgers’ Human Genetics Institute of New Jersey, home to RUCDR Infinite Biologics — the world’s largest university-based biorepository — announced…
New Research Achieves Direct Muscle Activation by LED Light
Researchers at the Dalhousie Medical School and the Brain Repair Centre in Halifax, Nova Scotia, have successfully stimulated muscle fibers…
MediciNova to Present ALS Study at International Symposium
Biopharmaceutical MediciNova, Inc. will be present at the 26th International Symposium on ALS/MND (amyotrophic lateral sclerosis/motor neurone…
ALS Organizations Launch Challenge To Improve Patients’ Communication
Two non-profit organizations, ALS Association and Prize4Life, have joined forces to launch a new challenge grant program called The ALS…
Novel Findings Corroborate Potential of Neurofilaments as ALS Biomarkers
The finding and validation of specific disease biomarkers are an unmet medical need for amyotrophic lateral sclerosis (ALS) early diagnosis, patient…
The ALS Association And CReATe Consortium Announce Funding For Two New ALS Studies
The ALS Association, a nonprofit organization of global research and support for people with ALS and the Clinical Research…
Cloud Pharmaceuticals and THERAMetrics to Collaborate on Drug Development for Orphan CNS Diseases, Including ALS
Cloud-based drug design and development company, Cloud Pharmaceuticals, Inc., recently announced it has partnered with THERAMetrics holding AG to collaborate on breakthrough treatments for orphan…